loading
Amneal Pharmaceuticals Inc stock is traded at $10.29, with a volume of 1.59M. It is up +0.39% in the last 24 hours and up +5.54% over the past month. Amneal Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and distributes generic pharmaceutical products for various dosage forms and therapeutic areas. It operates through Generic and Specialty Pharma divisions. The company's generics portfolio includes approximately 200 product families marketed in various dosage forms, such as solid oral doses comprising tablets, capsules, and powders; liquids; sterile injectables; nasal sprays; inhalation and respiratory products; ophthalmics; films; transdermal patches; and topicals, as well as soft gel, complex molecule, and drug-device combinations. It is also involved in the development, manufacture, and sale of branded pharmaceutical products primarily for central nervous system disorders and parasitic infections; and biosimilar products. In addition, the company offers licensed and owned, niche, and mature branded products, as well as a pipeline of 505(b)(2) products for various therapeutic areas that primarily includes Unithroid for endocrinologists and primary care physicians through a contracted salesforce. Amneal Pharmaceuticals, Inc. has a partnership agreement with MabXience S.L. for the development of Avastin, a biosimilar bevacizumab. The company has operations in North America, Asia, and Europe. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey.
See More
Previous Close:
$10.25
Open:
$10.23
24h Volume:
1.59M
Relative Volume:
0.99
Market Cap:
$3.23B
Revenue:
$2.68B
Net Income/Loss:
$-184.45M
P/E Ratio:
-15.12
EPS:
-0.6805
Net Cash Flow:
$229.23M
1W Performance:
+0.00%
1M Performance:
+5.54%
6M Performance:
+35.04%
1Y Performance:
+20.49%
1-Day Range:
Value
$10.13
$10.45
1-Week Range:
Value
$10.13
$10.62
52-Week Range:
Value
$6.685
$10.68

Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile

Name
Name
Amneal Pharmaceuticals Inc
Name
Phone
908-947-3120
Name
Address
400 Crossing Boulevard, 3rd Floor, Bridgewater
Name
Employee
5,210
Name
Twitter
@amnealpharma
Name
Next Earnings Date
2025-05-02
Name
Latest SEC Filings
Name
AMRX's Discussions on Twitter

Compare AMRX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
AMRX
Amneal Pharmaceuticals Inc
10.29 3.22B 2.68B -184.45M 229.23M -0.6805
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
145.41 65.38B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.10 44.75B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.12 40.97B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
19.78 22.50B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
415.34 19.04B 3.08B 1.24B 1.07B 25.61

Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-06-25 Initiated Goldman Buy
Feb-24-25 Upgrade JP Morgan Neutral → Overweight
Sep-06-24 Upgrade JP Morgan Underweight → Neutral
Apr-07-21 Resumed RBC Capital Mkts Sector Perform
Mar-08-21 Upgrade Goldman Sell → Buy
Dec-14-20 Upgrade Barclays Equal Weight → Overweight
Dec-14-20 Upgrade Guggenheim Neutral → Buy
Jul-27-20 Initiated Goldman Sell
May-12-20 Upgrade Guggenheim Sell → Neutral
Dec-12-19 Downgrade Raymond James Outperform → Mkt Perform
Nov-12-19 Downgrade JP Morgan Neutral → Underweight
Nov-07-19 Downgrade SVB Leerink Outperform → Mkt Perform
Jul-22-19 Upgrade SVB Leerink Mkt Perform → Outperform
Jul-11-19 Downgrade RBC Capital Mkts Outperform → Sector Perform
Jul-08-19 Upgrade Piper Jaffray Neutral → Overweight
Jun-11-19 Initiated Barclays Equal Weight
May-21-19 Upgrade Raymond James Mkt Perform → Strong Buy
Mar-20-19 Initiated SunTrust Buy
Mar-08-19 Downgrade SVB Leerink Outperform → Mkt Perform
Dec-14-18 Downgrade Morgan Stanley Overweight → Equal-Weight
Oct-16-18 Downgrade SunTrust Buy → Hold
Aug-13-18 Upgrade RBC Capital Mkts Sector Perform → Outperform
Jul-23-18 Initiated Morgan Stanley Overweight
Jun-22-18 Initiated B. Riley FBR, Inc. Buy
View All

Amneal Pharmaceuticals Inc Stock (AMRX) Latest News

pulisher
Oct 28, 2025

Brekiya Migraine Autoinjector Launch Could Be a Game Changer for Amneal Pharmaceuticals (AMRX) - Yahoo Finance

Oct 28, 2025
pulisher
Oct 28, 2025

Will Amneal Pharmaceuticals Inc. stock reach Wall Street targets2025 Big Picture & Free Daily Entry Point Trade Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Does Amneal Pharmaceuticals Inc. show high probability of rebound2025 Buyback Activity & Fast Gain Swing Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Is Amneal Pharmaceuticals Inc. stock resilient to inflationMarket Volume Summary & Technical Pattern Alert System - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Can Amneal Pharmaceuticals Inc. stock beat market expectations this quarterEarnings Risk Summary & High Accuracy Trade Alerts - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Is Amneal Pharmaceuticals Inc. stock a top momentum playTrade Entry Report & Short-Term Trading Opportunity Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

How high can Amneal Pharmaceuticals Inc. stock go2025 Earnings Impact & AI Enhanced Trading Signals - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Will Amneal Pharmaceuticals Inc. stock benefit from automationWeekly Trade Report & Safe Capital Growth Trade Ideas - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

How Amneal Pharmaceuticals Inc. stock compares to industry benchmarksWeekly Trend Report & Free Long-Term Investment Growth Plans - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

How to manage a losing position in Amneal Pharmaceuticals Inc.Earnings Overview Report & Fast Gaining Stock Strategy Reports - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Mycophenolate Pregnancy Registry: Key Insights for Investors - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

What analyst consensus says on Amneal Pharmaceuticals Inc. stockWeekly Trend Summary & Low Risk High Win Rate Stock Picks - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Why Amneal Pharmaceuticals Inc. stock could outperform in 2025Market Growth Report & Free Weekly Chart Analysis and Trade Guides - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Amneal Launches Brekiya®the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches - The Manila Times

Oct 27, 2025
pulisher
Oct 27, 2025

Candlestick signals on Amneal Pharmaceuticals Inc. stock todayJuly 2025 Snapshot & Free Real-Time Market Sentiment Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Amneal (NASDAQ: AMRX) launches Brekiya for migraine, exclusive at Walgreens and Sterling - Stock Titan

Oct 27, 2025
pulisher
Oct 27, 2025

Published on: 2025-10-27 03:37:22 - newser.com

Oct 27, 2025
pulisher
Oct 26, 2025

Published on: 2025-10-26 15:52:31 - newser.com

Oct 26, 2025

Amneal Pharmaceuticals Inc Stock (AMRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$47.12
price down icon 2.30%
$22.12
price down icon 0.67%
$10.29
price down icon 1.25%
drug_manufacturers_specialty_generic RDY
$14.60
price up icon 0.90%
$147.38
price down icon 1.05%
$415.34
price down icon 1.35%
Cap:     |  Volume (24h):